Hyperion Defi (HYPD) Research & Development (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Research & Development of $286764.0 for Q1 2026, down 57.39% year-over-year from $673043.0 in Q1 2025, and up 117.08% quarter-over-quarter from -$1.7 million in Q4 2025.
Hyperion Defi (HYPD) Research & Development (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Research & Development for 10 consecutive years, with $286764.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development fell 57.39% year-over-year to $286764.0; the TTM figure through Mar 2026 stood at -$344114.0 (up 89.73% YoY), while the FY2025 annual figure was $42165.0, down 89.7% from the prior year.
- Research & Development improved to $286764.0 in Q1 2026 per HYPD's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Research & Development topped out at $4.6 million in Q2 2024 and bottomed at -$12.1 million in Q4 2024.
- Historically, Research & Development has averaged $1.6 million across 5 years, with a median of $2.8 million in 2023.
- Annual changes were most pronounced in 2024 — Research & Development plunged 397.47% — and 2025, when it jumped 86.11%.
- Hyperion Defi's Research & Development stood at $2.2 million in 2022, then jumped by 84.56% to $4.1 million in 2023, then tumbled by 397.47% to -$12.1 million in 2024, then surged by 86.11% to -$1.7 million in 2025, then jumped by 117.08% to $286764.0 in 2026.
- Business Quant data shows HYPD's Research & Development at $286764.0 in Q1 2026, -$1.7 million in Q4 2025, and $373855.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | 58,491.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58,491.00 |
| Mar 31, 2026 | 286,764.00 |
| Dec 31, 2025 | -1.68 Mn |
| Sep 30, 2025 | 373,855.00 |
| Jun 30, 2025 | 674,578.00 |
| Mar 31, 2025 | 673,043.00 |
| Dec 31, 2024 | -12.09 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | 4.43 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Sep 30, 2023 | 3.58 Mn |
| Jun 30, 2023 | 2.81 Mn |
| Mar 31, 2023 | 2.52 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 3.88 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Mar 31, 2022 | 3.71 Mn |
| Dec 31, 2021 | 3.29 Mn |
| Sep 30, 2021 | 3.55 Mn |